Poseida Therapeutics, Inc. — Form D

Poseida Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-11. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Rafael J AmadoDirectorSan Diego, CA
Charles M BaumDirectorBoston, MA
Cynthia M CollinsDirectorSan Diego, CA
Luke M CorningDirectorSan Diego, CA
Mark J GergenDirectorSan Diego, CA
Marcea B LloydDirectorSan Diego, CA
John B SchmidDirectorSan Diego, CA
Mark J GergenExecutive OfficerSan Diego, CA
Harry J LeonhardtExecutive OfficerSan Diego, CA
Johanna M MyletExecutive OfficerSan Diego, CA
Brent J WarnerExecutive OfficerSAN DIEGO, CA
Kristin J YaremaExecutive OfficerSan Diego, CA
Robert LyonsDirectorGrand Cayman, E9
Mark GergenDirectorSan Diego, CA
Mark GergenExecutive OfficerSan Diego, CA
Mark GergenRelated PersonSan Diego, CA
John SchmidRelated PersonSan Diego, CA
Sean MurphyRelated PersonSan Diego, CA
David HirschDirectorSan Diego, CA
David HirschRelated PersonSan Diego, CA
John J SchmidDirectorSan Diego, CA
Noah J BerkowitzDirectorSan Diego, CA
Marcea Bland LloydDirectorSan Diego, CA
Marcea Bland LloydRelated PersonSan Diego, CA
Eric OstertagDirectorSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2019-04-22D$150.0M$142.1M
2018-04-03D$30.5M$30.5M
2017-08-03D$15.0M$11.2M
2015-12-24D$36.0M$23.0M

More